These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7950850)

  • 41. The business of addiction treatment: A research agenda.
    Kimberly JR; McLellan AT
    J Subst Abuse Treat; 2006 Oct; 31(3):213-9. PubMed ID: 16996384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The medicalization of addiction treatment professionals.
    Roy AK; Miller MM
    J Psychoactive Drugs; 2012; 44(2):107-18. PubMed ID: 22880538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of drug addicts: an alternative].
    Stigler M
    Rev Med Suisse Romande; 1993 Jan; 113(1):65-8. PubMed ID: 8381983
    [No Abstract]   [Full Text] [Related]  

  • 44. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can the Treatment Services Review be used to estimate the costs of addiction and ancillary services?
    French MT; Roebuck MC; McLellan AT; Sindelar JL
    J Subst Abuse; 2000; 12(4):341-61. PubMed ID: 11452838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
    Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
    J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using health insurance claims data to analyze substance abuse charges and utilization.
    Garnick DW; Horgan CM; Hendricks AM; Comstock C
    Med Care Res Rev; 1996 Sep; 53(3):350-68. PubMed ID: 10172725
    [No Abstract]   [Full Text] [Related]  

  • 48. Addiction medicine in the '90s: a case study.
    Brandenburger JS
    Calif Hosp; 1993; 7(1):12-3. PubMed ID: 10171357
    [No Abstract]   [Full Text] [Related]  

  • 49. Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?
    Dismuke CE; French MT; Salomé HJ; Foss MA; Scott CK; Dennis ML
    J Subst Abuse Treat; 2004 Oct; 27(3):253-63. PubMed ID: 15501378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benefit-cost analysis of drug abuse prevention programs: a macroscopic approach.
    Kim S; Coletti SD; Crutchfield CC; Williams C; Hepler N
    J Drug Educ; 1995; 25(2):111-27. PubMed ID: 7658292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How many people need substance abuse treatment in North Carolina and how much does it cost?
    McCarthy P; Kissling G; Dirkers J
    N C Med J; 1993 May; 54(5):209-12. PubMed ID: 8389988
    [No Abstract]   [Full Text] [Related]  

  • 52. Mental health and substance abuse coverage under health reform.
    Arons BS; Frank RG; Goldman HH; McGuire TG; Stephens S
    Health Aff (Millwood); 1994; 13(1):192-205. PubMed ID: 8188135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effectiveness of drug treatment.
    Gerstein DR
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug treatment takes a hit. As substance abuse has surged among teens, coverage for care has been curtailed.
    Gardner J
    Mod Healthc; 1996 Oct; 26(43):66, 68, 70-2. PubMed ID: 10172795
    [No Abstract]   [Full Text] [Related]  

  • 55. Does America spend enough on addiction treatment? Results from public opinion surveys.
    French MT; Homer JF; Nielsen AL
    J Subst Abuse Treat; 2006 Oct; 31(3):245-54. PubMed ID: 16996387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Applying benefit-cost analysis to substance use prevention programs.
    Plotnick RD
    Int J Addict; 1994 Feb; 29(3):339-59. PubMed ID: 8188432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug addiction treatment guide released.
    Miller JL
    Am J Health Syst Pharm; 1999 Nov; 56(22):2276. PubMed ID: 10582814
    [No Abstract]   [Full Text] [Related]  

  • 58. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemical dependency treatment: the integration of the alcoholism and drug addiction/use treatment systems.
    Rawson RA
    Int J Addict; 1990-1991; 25(12A):1515-36. PubMed ID: 1966837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.